English 
Introduction: The Challenge of Pharmaceutical Wastewater
Pharmaceutical wastewater contains complex pollutants, including high concentrations of organics, residual drugs, and chemicals, posing serious environmental risks. A Cambodian pharmaceutical manufacturer addressed this challenge with an integrated treatment solution featuring a DAF system, MBBR media, a sludge dewatering machine, and other advanced processes to ensure compliant discharge.
Core processing flow:
DAF system: As a pre-treatment unit, it effectively removes suspended solids and a portion of chemical oxygen demand (COD) through dissolved air flotation technology.
MBBR technology: By adopting high-performance biofilm carriers, it can enhance the attachment and degradation efficiency of microorganisms, ensuring the stable operation of the biological treatment system.
Sludge dewatering machine: It can effectively reduce the volume of sludge, lower the treatment cost, and make the sludge treatment process safer.
Anaerobic reactor: Suitable for the removal of high-load organic matter, it converts pollutants into biogas, achieving energy recovery.
This project also adopted advanced treatment technologies to meet strict standards. The tailor-made water reuse plan further promotes water resource conservation and is in line with sustainable industrial practices.
Why Choose Our Solution?
Our expertise in pharmaceutical wastewater treatment ensures reliable, cost-effective systems designed for Cambodia’s specific conditions. From the DAF system to the sludge dewatering machine, each component is optimized for efficiency and longevity.
Conclusion
This Cambodian project demonstrates how integrated technologies can tackle complex wastewater challenges while promoting environmental stewardship and operational sustainability.
